Nurix Therapeutics, INC. (NRIX) SEC Filings — 2025
15 SEC filings for Nurix Therapeutics, INC. (NRIX) in 2025.
Filings
- Nurix Therapeutics, INC. 8-K Filing — 8-K · Dec 9, 2025
- Nurix Therapeutics, INC. 8-K Filing — 8-K · Nov 10, 2025
- Nurix Therapeutics Files 8-K — 8-K · Oct 22, 2025
- Nurix Therapeutics Files 8-K — 8-K · Oct 22, 2025
- Nurix's Losses Widen to $186M Amid Soaring R&D Costs — 10-Q · Oct 9, 2025
- Nurix Therapeutics Files 8-K — 8-K · Sep 3, 2025
- Nurix Therapeutics Names New CEO, Restructures Leadership — 8-K · Aug 22, 2025
- Nurix Collaboration Revenue Jumps 38% in Q2 — 10-Q · Jul 9, 2025
- Nurix Therapeutics Files 8-K — 8-K · Jun 12, 2025
- Nurix Therapeutics Files 8-K on Shareholder Votes & Exhibits — 8-K · May 19, 2025
- Nurix Therapeutics Files Q1 2025 10-Q — 10-Q · Apr 8, 2025
- Nurix Therapeutics Files 2025 Proxy Statement — DEF 14A · Mar 28, 2025
- Nurix Therapeutics Appoints New CMO, Director — 8-K · Mar 13, 2025
- Nurix Therapeutics Files 2024 Annual Report — 10-K · Jan 28, 2025
- Nurix Therapeutics Files 8-K on Financials — 8-K · Jan 13, 2025